Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Bath & Body Works Reports 2024 Fourth Quarter and Full-Year Results and Provides 2025 Guidance

In This Article:

Bath & Body Works, Inc.
Bath & Body Works, Inc.
  • Fourth quarter 2024 net sales of $2.8 billion and earnings per diluted share of $2.09, both exceeding guidance

  • Fourth quarter net sales performance driven by strong traffic and conversion, building on Q3 momentum

  • Company provides 2025 annual guidance of 1% to 3% net sales growth and earnings per diluted share of $3.25 to $3.60

  • Board of Directors authorizes new $500M share repurchase program

COLUMBUS, Ohio, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Bath & Body Works, Inc. (NYSE: BBWI), a global leader in personal care and home fragrance, today reported fourth quarter and full-year fiscal 2024 results.

Gina Boswell, CEO of Bath & Body Works, commented, “Our team delivered strong performance that exceeded expectations on both the top and bottom line in the critical fourth quarter. This success was driven by our product innovation, strong execution and the outstanding customer experience provided by our associates.”

Boswell added, “Our strategy is working, and we are driving topline growth through product innovation, enhanced marketing and technology, and by extending our reach through category adjacencies and international expansion. Despite complex challenges facing the broader retail sector, we ended the second half of the year strong. As we enter 2025, we have a lot to be excited about, and we are eager to build on our momentum.”

Fourth Quarter 2024 Results

The company reported net sales of $2,788 million for the 13-week fiscal fourth quarter ended February 1, 2025, a decrease of 4.3% compared to net sales of $2,912 million for the 14-week fiscal fourth quarter ended February 3, 2024. Fourth quarter 2024 net sales incurred a headwind of approximately 500 basis points due to the shifted fiscal calendar, resulting from and including the extra week in 2023.

The company reported earnings per diluted share of $2.09 for the fourth quarter of 2024, compared to $2.55 last year. Fourth quarter operating income was $678 million compared to $696 million last year, and net income was $453 million compared to $579 million last year.

Reported fourth quarter 2023 results include a $112 million tax benefit related to the partial release of a valuation allowance on a deferred tax asset, an $8 million pre-tax impairment charge ($6 million net of tax of $2 million) related to an equity method investment and a $6 million pre-tax gain ($5 million net of tax of $1 million) associated with the early extinguishment of debt. Excluding these items, adjusted fourth quarter 2023 earnings per diluted share was $2.06 and adjusted net income was $469 million.